* HIV-2 Proviral DNA Qualitative Detection: Direct molecular real-time PCR amplification targeting highly conserved regions of the HIV-2 genome (such as the LTR, gag, or pol gene sequences) to confirm the presence (Detected) or absence (Not Detected) of integrated cellular provirus. * Internal Control (Human Housekeeping Gene) Amplification: Co-amplification of an endogenous human gene (such as \beta-globin or RNase P) to verify adequate cellular extraction, sample integrity, and complete absence of PCR inhibitors. * Molecular Pathologist Remarks: Detailed clinical interpretation mapping proviral DNA outputs against serological profiles (HIV-1 vs. HIV-2 antibody differentiation), regional exposure risks, and clinical management pathways.

MOLECULAR BIOLOGY

REAL-TIME POLYMERASE CHAIN REACTION (REAL-TIME PCR) The EDTA whole blood specimen is processed using automated Real-Time Polymerase Chain Reaction (qPCR) on isolated cellular fractions: * Cellular Lysis & PBMC Harvest: Whole blood collected in EDTA is processed to extract total genomic and proviral DNA from peripheral blood mononuclear cells (lymphocytes and monocytes). * Automated DNA Extraction & Purification: Magnetic-silica bead-based extraction protocols lyse host leukocyte cell membranes and nuclear envelopes, binding high-molecular-weight genomic DNA while washing away cellular proteins, hemoglobin, and chemical contaminants. * Sequence-Specific Target Amplification: Dual-target sequence primers specific to the HIV-2 genome amplify the target sequence through automated thermal denaturation, annealing, and polymer-driven extension cycles. * Fluorogenic Hydrolysis Probe Detection: Dual-labeled fluorescent hybridization probes (TaqMan chemistry) hybridize specifically to the HIV-2 target amplicon. 5'-exonuclease activity cleaves the probe, generating an optical fluorescent signal directly proportional to accumulated PCR product. * Real-Time Signal Verification: Real-time optical sensors track exponential fluorescence growth cycle-by-cycle (C_t value), delivering high analytical sensitivity and eliminating cross-reactivity with HIV-1 sequences.

EDTA Whole Blood 3ML

CRITICAL PREPARATION & SAMPLE LOGISTICS: * No Fasting Required: Strict fasting is entirely unnecessary. Routine meals, fluid intake, and daily non-antiviral medications do not alter intracellular proviral DNA. * Sample Type - Whole Blood Mandatory: Requires 3 mL of fresh whole blood collected in a purple-top EDTA tube. Centrifuged serum or isolated plasma cannot be used for proviral DNA assays because provirus resides inside host leukocyte nuclei, requiring intact white blood cells. * Do Not Freeze Whole Blood Before Processing: EDTA whole blood should be maintained at 2–8^\circ\text{C} or ambient room temperature (20–25^\circ\text{C}) during local transport. Do not freeze whole blood before cellular lysis, as freezing causes extensive red cell hemolysis and interferes with leukocyte pellet harvesting. * Avoid Heparin Anticoagulant: Heparin is a potent inhibitor of DNA polymerase and causes complete PCR reaction failure. Only EDTA tubes are accepted. * Document Antiretroviral Therapy (ART): Note any ongoing antiretroviral regimens or post-exposure prophylaxis (PEP) on the laboratory requisition form.

QUESTION 1: Why does the HIV-2 Proviral DNA PCR Detection Test require a 2-day (48-hour) turnaround window? ANSWER: Delivering absolute diagnostic precision for an intracellular proviral DNA assay requires rigorous multi-stage processing. This includes harvesting peripheral blood mononuclear cells from whole blood, cell lysis, automated magnetic-bead DNA extraction, setting up sequence-specific real-time PCR master mixes, executing thermal cycling with internal controls, analyzing fluorescence curves, and final verification by our molecular pathology team. QUESTION 2: What is the primary biological difference between HIV-1 and HIV-2? ANSWER: HIV-1 and HIV-2 are distinct retroviruses with roughly 55% sequence homology. HIV-2 has a longer asymptomatic latency period, slower CD4 cell decline, and lower rates of transmission compared to HIV-1. Crucially, HIV-2 is naturally resistant to certain classes of anti-HIV medications (like NNRTIs), making precise laboratory identification essential. QUESTION 3: What is "Proviral DNA," and why is it tested instead of plasma RNA for HIV-2? ANSWER: When HIV enters a host cell, its reverse transcriptase converts viral RNA into DNA, which integrates directly into host cellular chromosomes—this integrated form is called proviral DNA. Because HIV-2 produces very low levels of circulating plasma RNA (often below standard detection limits), testing for proviral DNA inside white blood cells provides a far more reliable method to confirm infection. QUESTION 4: Why cannot serum or plasma be used for this specific test? ANSWER: Proviral DNA exists inside the cell nucleus of infected white blood cells (lymphocytes and monocytes). Centrifuging blood into serum or cell-free plasma removes the host cells containing the integrated DNA. Therefore, EDTA whole blood containing intact leukocytes is strictly mandatory. QUESTION 5: Do I need to fast before providing a blood sample for this test? ANSWER: No. Fasting is entirely unnecessary. Routine meals, beverages, and daily activities do not alter intracellular DNA sequences, allowing blood collection at any time of day. QUESTION 6: Why is Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) resistance important in HIV-2? ANSWER: HIV-2 possesses natural structural variations in its reverse transcriptase enzyme that render standard NNRTI medications—such as Efavirenz, Nevirapine, and Rilpivirine—completely ineffective. Patients with HIV-2 must be treated with regimens based on Integrase Inhibitors (like Dolutegravir) or boosted Protease Inhibitors (like Darunavir). QUESTION 7: Can an individual be co-infected with both HIV-1 and HIV-2 simultaneously? ANSWER: Yes. Dual infection with both HIV-1 and HIV-2 can occur, particularly in endemic geographic areas or through multiple exposures. In such cases, testing for both HIV-1 RNA/DNA and HIV-2 proviral DNA is required to confirm whether dual infection is present or if the result is simply serological antibody cross-reactivity. QUESTION 8: What is the "Window Period" for this molecular proviral DNA test? ANSWER: Proviral DNA integrates into host cells during early viral replication, typically becoming detectable within 10 to 14 days following exposure. However, because HIV-2 replicates more slowly than HIV-1, confirmation guidelines recommend repeat testing or clinical follow-up at 4 to 12 weeks for high-risk exposures. QUESTION 9: Why is this test used for diagnosing newborn babies exposed to HIV-2? ANSWER: Maternal IgG antibodies against HIV-2 cross the placenta during pregnancy and can remain in the baby's bloodstream for up to 18 months. As a result, antibody tests will read positive even in an uninfected infant. Direct molecular detection of proviral DNA inside the baby's white blood cells confirms or rules out transmission. QUESTION 10: What does a "Not Detected" proviral DNA result mean? ANSWER: A "Not Detected" result indicates that HIV-2 proviral DNA was not identified above the analytical limit of detection in the patient's circulating white blood cells. If testing was performed after the window period, it provides strong evidence against HIV-2 infection. QUESTION 11: Can everyday stress, common viral colds, or medications alter my PCR test results? ANSWER: No. Everyday stress, colds, or common antibiotics cannot alter retroviral DNA sequences or cause sequence-specific real-time PCR primers to cross-react. QUESTION 12: Is this venous whole blood collection procedure safe? ANSWER: Yes, completely safe and standard. It requires a routine, sterile venous blood collection (3 mL) from an arm vein that takes only a minute and carries minimal physical risk. QUESTION 13: How does real-time PCR ensure there are no false negatives? ANSWER: Every reaction well includes an internal control that targets a natural human housekeeping gene (\beta-globin or RNase P). If this human gene fails to amplify, the laboratory flags the test as invalid, preventing false-negative reporting due to poor DNA extraction or PCR inhibitors. QUESTION 14: Where is HIV-2 predominantly found geographically? ANSWER: HIV-2 is most prevalent in West African nations (e.g., Senegal, Guinea-Bissau, Côte d'Ivoire, Mali) and former Portuguese territories, with documented clinical clusters in parts of Western Europe and western/southern coastal regions of India (such as Maharashtra and Goa). QUESTION 15: What does an "Inconclusive" or "Inhibitory" result mean? ANSWER: An inconclusive result indicates that the internal control failed to amplify properly, often due to biological substances in the blood (such as excess heparin, degraded DNA, or high bilirubin) that inhibit PCR enzymes. The laboratory will arrange a repeat draw to re-run the assay. QUESTION 16: Can receiving a routine vaccine (like Hepatitis B or Tetanus) cause a positive result on this test? ANSWER: No. Routine vaccines stimulate host antibodies against specific target antigens, but they do not introduce HIV-2 genetic material into your genome and cannot trigger a positive result on a proviral DNA assay. QUESTION 17: How sensitive is the qualitative real-time proviral PCR method? ANSWER: Real-time proviral PCR is highly sensitive, capable of detecting as few as 10 to 50 copies of integrated proviral DNA per million peripheral blood mononuclear cells, ensuring robust detection even in patients with low proviral loads. QUESTION 18: What is the standard immediate medical step if the test returns "Detected"? ANSWER: A "Detected" result confirms active HIV-2 infection. The immediate step is to consult an infectious disease or HIV physician, who will stage the disease using CD4 counts, evaluate baseline organ function (LFT/KFT), and initiate an appropriate, NNRTI-sparing antiretroviral treatment plan. QUESTION 19: How can our family securely access and download our final digital PDF report file? ANSWER: As soon as the molecular PCR analysis is completed, verified, and signed off by our laboratory pathology team, your secure digital report can be downloaded instantly from www.drpatholab.in using your registered credentials. QUESTION 20: Are my personal health records, viral profiles, and molecular laboratory data kept private? ANSWER: Absolute adherence to strict medical privacy frameworks, sample identity logging protocols, and encrypted digital channels across our laboratory infrastructure guarantees that your entire diagnostic and molecular profile remains confidential and secure.